Safety and Effectiveness of PCSK9 Inhibitors in Orthotopic Heart Transplant Patients

被引：0

作者：

Sammour, Yasser ^{[1
]}

Austin, Bethany A. ^{[1
]}

Borkon, Michael ^{[1
]}

Everley, Mark P. ^{[1
]}

Fendler, Timothy J. ^{[1
]}

Khumri, Taiyeb M. ^{[1
]}

Lawhorn, Stephanie L. ^{[1
]}

Magalski, Anthony ^{[1
]}

Nassif, Michael E. ^{[1
]}

Vodnala, Deepthi ^{[1
]}

Kao, Andrew C. ^{[1
]}

Sperry, Brett W. ^{[1
]}

机构：

[1] St Lukes Mid Amer Heart Inst, Kansas City, MO USA

来源：

JOURNAL OF CARDIAC FAILURE | 2020年 / 26卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

054

引用

页码：S22 / S22

页数：1

共 50 条

[31] Estimated Percentage of Patients With Stable Coronary Heart Disease Candidates for PCSK9 Inhibitors
Cordero, Alberto
Facila, Lorenzo
Galve, Enrique
Gonzalez Juanatey, Jose Ramon
REVISTA ESPANOLA DE CARDIOLOGIA, 2019, 72 (06): : 518 - 519
[32] COST EFFECTIVENESS OF AN OUTCOME BASED REIMBURSEMENT MODEL OF PCSK9 INHIBITORS
Oren, Ohad
Oren, Michal
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1753 - 1753
[33] The cost-effectiveness of PCSK9 inhibitors - The Australian healthcare perspective
Kumar, Radya
Tonkin, Andrew
Liew, Danny
Zomer, Ella
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 267 : 183 - 187
[34] PCSK9 Inhibitors Economics and Policy
Hlatky, Mark A.
Kazi, Dhruv S.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (21) : 2677 - 2687
[35] Clinical Shortcuts: PCSK9 Inhibitors
Steiner, S.
Berent, R.
Derfler, K.
Sinzinger, H.
Auer, J.
JOURNAL FUR KARDIOLOGIE, 2016, 23 (1-2): : 30 - 34
[36] Oral PCSK9 Inhibitors: Will They Work?
Lale Tokgözoğlu
Angela Pirillo
Alberico L. Catapano
Current Atherosclerosis Reports, 2025, 27 (1)
[37] Lipid lowering with PCSK9 inhibitors
Razvan T. Dadu
Christie M. Ballantyne
Nature Reviews Cardiology, 2014, 11 : 563 - 575
[38] PCSK9 Inhibitors for Statin Intolerance?
Waters, David D.
Hsue, Priscilla Y.
Bangalore, Sripal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (15): : 1571 - 1572
[39] Lipid lowering with PCSK9 inhibitors
Dadu, Razvan T.
Ballantyne, Christie M.
NATURE REVIEWS CARDIOLOGY, 2014, 11 (10) : 563 - 575
[40] PCSK9 inhibitors: drug safety prediction using gene variants
Reactions Weekly, 2017, 1681 (1) : 12 - 12

← 1 2 3 4 5 →